Literature DB >> 11897610

In vitro antifungal susceptibilities of Trichosporon species.

Niki I Paphitou1, Luis Ostrosky-Zeichner, Victor L Paetznick, Jose R Rodriguez, Enuo Chen, John H Rex.   

Abstract

The in vitro activities of amphotericin B, itraconazole, fluconazole, voriconazole, posaconazole, and ravuconazole against 39 isolates of Trichosporon spp. were determined by the NCCLS M27-A microdilution method. The azoles tested appeared to be more potent than amphotericin B. Low minimal fungicidal concentration/MIC ratios were observed for voriconazole, posaconazole, and ravuconazole, suggesting fungicidal activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897610      PMCID: PMC127118          DOI: 10.1128/AAC.46.4.1144-1146.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  A case of Trichosporon beigelii endocarditis.

Authors:  M Y Mooty; S S Kanj; M Y Obeid; G Y Hassan; G F Araj
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-02       Impact factor: 3.267

Review 2.  Trichosporonosis.

Authors:  T J Walsh
Journal:  Infect Dis Clin North Am       Date:  1989-03       Impact factor: 5.982

3.  In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.

Authors:  P Nenoff; U Oswald; U F Haustein
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

4.  Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia.

Authors:  J R Ebright; M R Fairfax; J A Vazquez
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

5.  In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.

Authors:  K Uchida; Y Nishiyama; N Yokota; H Yamaguchi
Journal:  J Antibiot (Tokyo)       Date:  2000-10       Impact factor: 2.649

6.  Transmission of Trichosporon asahii oesophagitis by a contaminated endoscope.

Authors:  C Lo Passo; I Pernice; A Celeste; G Perdichizzi; F Todaro-Luck
Journal:  Mycoses       Date:  2001       Impact factor: 4.377

Review 7.  Trichosporon beigelii infection: experience in a regional burn center.

Authors:  M J Cawley; G R Braxton; L R Haith; K J Reilly; R E Guilday; M L Patton
Journal:  Burns       Date:  2000-08       Impact factor: 2.744

8.  Trichosporon species infection in bone marrow transplanted patients.

Authors:  M L Moretti-Branchini; K Fukushima; A Z Schreiber; K Nishimura; P M Papaiordanou; P Trabasso; R Tanaka; M Miyaji
Journal:  Diagn Microbiol Infect Dis       Date:  2001-03       Impact factor: 2.803

9.  Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.

Authors:  O Uzun; S Arikan; S Kocagöz; B Sancak; S Unal
Journal:  Diagn Microbiol Infect Dis       Date:  2000-10       Impact factor: 2.803

Review 10.  Trichosporon beigelii infection: a review.

Authors:  J Hoy; K C Hsu; K Rolston; R L Hopfer; M Luna; G P Bodey
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec
View more
  48 in total

1.  Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.

Authors:  Rama Falk; Dana G Wolf; Mervyn Shapiro; Itzhack Polacheck
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

2.  Clinical case of endocarditis due to Trichosporon inkin and antifungal susceptibility profile of the organism.

Authors:  Jose M Ramos; Manuel Cuenca-Estrella; Felix Gutierrez; Matilde Elia; Juan L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts.

Authors:  Carolina Serena; Francisco Javier Pastor; Montserrat Ortoneda; Javier Capilla; Nicole Nolard; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

Review 4.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

5.  Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.

Authors:  Moan Shane Tsai; Yun Liang Yang; An Huei Wang; Lih Shinn Wang; Daniel C T Lu; Ci Hong Liou; Li Yun Hsieh; Chi Jung Wu; Ming Fang Cheng; Zhi Yuan Shi; Hsiu Jung Lo
Journal:  Mycopathologia       Date:  2012-02-09       Impact factor: 2.574

6.  Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H, 31H-phthalocyanine (ZnPc).

Authors:  J C Junqueira; A O C Jorge; J O Barbosa; R D Rossoni; S F G Vilela; A C B P Costa; F L Primo; J M Gonçalves; A C Tedesco; J M A H Suleiman
Journal:  Lasers Med Sci       Date:  2012-01-26       Impact factor: 3.161

7.  Microbiological characteristics of medically important Trichosporon species.

Authors:  Hou-Min Li; Hong-Tao Du; Wei Liu; Zhe Wan; Ruo-Yu Li
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

Review 8.  Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature.

Authors:  Corrado Girmenia; Livio Pagano; Bruno Martino; Domenico D'Antonio; Rosa Fanci; Giorgina Specchia; Lorella Melillo; Massimo Buelli; Giampaolo Pizzarelli; Mario Venditti; Pietro Martino
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 9.  Update on the genus Trichosporon.

Authors:  Thomas C Chagas-Neto; Guilherme M Chaves; Arnaldo L Colombo
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

10.  Supplemental utility of nested PCR for the pathological diagnosis of disseminated trichosporonosis.

Authors:  Makoto Sano; Masahiko Sugitani; Toshiyuki Ishige; Taku Homma; Kentaro Kikuchi; Keishin Sunagawa; Yukari Obana; Yuki Uehara; Kazunari Kumasaka; Kumi Uenogawa; Sumiko Kobayashi; Yoshihiro Hatta; Jin Takeuchi; Norimichi Nemoto
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.